November 25, 2016 - By Darrin Black · 0 Comments
The stock of Balchem Corporation (NASDAQ:BCPC) registered a decrease of 3.95% in short interest. BCPC’s total short interest was 1.40 million shares in November as published by FINRA. Its down 3.95% from 1.46 million shares, reported previously. With 79,800 shares average volume, it will take short sellers 18 days to cover their BCPC’s short positions. The short interest to Balchem Corporation’s float is 4.48%. About 18,366 shares traded hands. Balchem Corporation (NASDAQ:BCPC) has risen 22.57% since April 22, 2016 and is uptrending. It has outperformed by 17.16% the S&P500.
Balchem Corporation is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The company has a market cap of $2.43 billion. The Firm operates in four divisions: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. It has a 44.96 P/E ratio. The Company’s SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, grain snacks and cereal ingredients.
Insitutional Activity: The institutional sentiment decreased to 1.21 in 2016 Q2. Its down 0.01, from 1.22 in 2016Q1. The ratio turned negative, as 11 funds sold all Balchem Corporation shares owned while 54 reduced positions. 14 funds bought stakes while 65 increased positions. They now own 24.68 million shares or 4.84% less from 25.93 million shares in 2016Q1.
Fred Alger, a New York-based fund reported 311,422 shares. Deutsche Bancshares Ag owns 39,115 shares or 0% of their US portfolio. Legal And General Grp Inc Public Limited Com last reported 7,061 shares in the company. Moreover, State Common Retirement Fund has 0.04% invested in Balchem Corporation (NASDAQ:BCPC) for 454,904 shares. Creative Planning last reported 0% of its portfolio in the stock. Martingale Asset Limited Partnership has invested 0.01% of its portfolio in Balchem Corporation (NASDAQ:BCPC). Vanguard Inc, a Pennsylvania-based fund reported 2.53M shares. Stephens Invest Mngmt Grp Llc has 0.71% invested in the company for 363,754 shares. Louisiana State Employees Retirement accumulated 14,000 shares or 0.04% of the stock. Teachers Retirement Systems Of The State Of Kentucky holds 11,450 shares or 0.01% of its portfolio. Geode Capital Ltd Co accumulated 0.01% or 225,543 shares. Assetmark Inc has 420 shares for 0% of their US portfolio. Moreover, Strs Ohio has 0.05% invested in Balchem Corporation (NASDAQ:BCPC) for 183,800 shares. Proshare Advsr Lc last reported 4,559 shares in the company. Commonwealth Equity Svcs Inc holds 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 9,490 shares.
Insider Transactions: Since July 13, 2016, the stock had 0 insider purchases, and 8 selling transactions for $6.99 million net activity. 16,600 shares were sold by ROSSI DINO A, worth $1.03 million. Houston Matthew David had sold 4,000 shares worth $271,320. 12,000 shares were sold by Backus William A., worth $823,680. Shares for $104,619 were sold by MCMILLAN EDWARD.
Out of 2 analysts covering Balchem (NASDAQ:BCPC), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Balchem has been the topic of 2 analyst reports since March 8, 2016 according to StockzIntelligence Inc. Sidoti downgraded Balchem Corporation (NASDAQ:BCPC) on Tuesday, March 8 to “Neutral” rating. On Friday, November 4 the stock rating was downgraded by Pivotal Research to “Sell”.
Balchem Corporation (Balchem), incorporated on January 30, 1967, is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Firm operates in four divisions: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. The Firm sells its products through its own sales force, independent distributors and sales agents. The Company’s SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, ready-to-eat cereals, grain snacks and cereal ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. The Company’s Industrial Products segment provides Choline Chloride and methylamines. The Company’s subsidiaries include SensoryEffects, Inc. (SE), SensoryEffects Cereal Systems, Inc. (SECS), BCP Ingredients, Inc. (BCP) and Aberco, Inc. (Aberco).
More notable recent Balchem Corporation (NASDAQ:BCPC) news were published by: Fool.com which released: “Balchem Corporation Sees Steady Health and Nutrition Growth” on November 08, 2016, also Fool.com with their article: “Balchem Corporation Sees a Bright Future in Human Nutrition Markets” published on August 11, 2016, Marketwatch.com published: “Balchem Corp. NASDAQ: BCPC” on October 18, 2010. More interesting news about Balchem Corporation (NASDAQ:BCPC) were released by: Quotes.Wsj.com and their article: “News Balchem Corp.BCPC” published on February 12, 2011 as well as Fool.com‘s news article titled: “Balchem Corporation Revenue Drops on Weak Energy Demand” with publication date: February 29, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black